BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1910891)

  • 1. Improving colorectal cancer screening in a medical residents' primary care clinic.
    Struewing JP; Pape DM; Snow DA
    Am J Prev Med; 1991; 7(2):75-81. PubMed ID: 1910891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of family physicians in increasing annual fecal occult blood test screening coverage: a prospective intervention study.
    Vinker S; Nakar S; Rosenberg E; Kitai E
    Isr Med Assoc J; 2002 Jun; 4(6):424-5. PubMed ID: 12073414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer on the front line.
    Lemon SC; Zapka JG; Estabrook B; Erban S; Luckmann R
    Am J Gastroenterol; 2003 Apr; 98(4):915-23. PubMed ID: 12738477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
    Young WF; McGloin J; Zittleman L; West DR; Westfall JM
    J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.
    Schroy PC; Geller AC; Crosier Wood M; Page M; Sutherland L; Holm LJ; Heeren T
    Prev Med; 2001 Nov; 33(5):381-91. PubMed ID: 11676578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does use of the Coloscreen Self-Test improve patient compliance with fecal occult blood screening?
    Park SI; Saxe JC; Weesner RE
    Am J Gastroenterol; 1993 Sep; 88(9):1391-4. PubMed ID: 8362837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
    Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center.
    Fitzgibbon ML; Ferreira MR; Dolan NC; Davis TC; Rademaker AW; Wolf MS; Liu D; Gorby N; Schmitt BP; Bennett CL
    Health Promot Pract; 2007 Jul; 8(3):273-81. PubMed ID: 17606952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to colorectal cancer screening: inadequate knowledge by physicians.
    Gennarelli M; Jandorf L; Cromwell C; Valdimarsdottir H; Redd W; Itzkowitz S
    Mt Sinai J Med; 2005 Jan; 72(1):36-44. PubMed ID: 15682261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of an evidence-based lecture and clinical prompt as methods to improve quality of care in colorectal cancer screening.
    Seres KA; Kirkpatrick AC; Tierney WM
    Am J Gastroenterol; 2009 Feb; 104(2):420-5. PubMed ID: 19190610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge of colorectal cancer among older persons.
    Weinrich SP; Weinrich MC; Boyd MD; Johnson E; Frank-Stromborg M
    Cancer Nurs; 1992 Oct; 15(5):322-30. PubMed ID: 1423251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
    Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
    J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening.
    Ling BS; Schoen RE; Trauth JM; Wahed AS; Eury T; Simak DM; Solano FX; Weissfeld JL
    Arch Intern Med; 2009 Jan; 169(1):47-55. PubMed ID: 19139323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening: physician attitudes and practices.
    Taylor ML; Anderson R
    WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.